Overcoming Barriers to Eliminate Hepatitis C, An Issue of Infectious Disease Clinics of North America
- 1st Edition, Volume 32-2 - May 24, 2018
- Latest edition
- Authors: Camilla S. Graham, Stacey B. Trooskin
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 5 8 4 0 3 - 6
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 5 8 4 0 4 - 3
The field of HCV has changed perhaps faster than any other field in medicine. The Guest Editors have strived to create an issue that is a state-of-the-art analysis of solutions to… Read more
Purchase options
The field of HCV has changed perhaps faster than any other field in medicine. The Guest Editors have strived to create an issue that is a state-of-the-art analysis of solutions to specific challenges faced in the United States and globally in implementing HCV elimination strategies. They believe that clinicians now have the tools and road maps needed to accomplish this goal. The clinical review articles in this issue accomplish that: Using Existing Health Care Infrastructure To Expand HCV Care; Creating A Reproducible Health Economic Model To Describe The Burden Of HCV And Cost Of Treatment In Any Country; The Best Uses Of Cost-Effectiveness Models In HCV; Increasing Access To HCV Care In Corrections; Cure As Prevention Strategies For HCV In People Who Inject Drugs; Australia Will Eliminate HCV – How It Works; New York Is The First State In The US To Develop An HCV Elimination Strategy; When HCV Diagnostics Are The Barrier To Care; Key Findings From The Checs HCV Cohort Study; Strategies To Reduce HCV Reinfection Rates In People Who Inject Drugs; Strategies To Reduce HCV Reinfection Rates In Men Who Have Sex With Other Men; The Value Of Curing HCV From A Payer’s Perspective; How To Expand Care Capacity In HCV; Strategies To Eliminate HCV In The HIV Coinfected Population; and The US Veteran’s Administration: Lessons Learned And Best Practices For HCV Elimination.
Preface: Removing the Barriers from the Path to Eliminate Hepatitis C
Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic
Hepatitis Cohort Study Status and Review of Findings
Elimination of Hepatitis C Virus in Australia: Laying the Foundation
Hepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success
Localized US Efforts to Eliminate Hepatitis C
New Treatments Have Changed the Game: Hepatitis C Treatment in Primary Care
Five Questions Concerning Managing Hepatitis C in the Justice System: Finding
Practical Solutions for Hepatitis C Virus Elimination
Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy:
A Review of Best Practice
Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs
Understanding and Addressing Hepatitis C Virus Reinfection Among Men Who Have Sex with Men
Hepatitis C Virus Elimination in the Human Immunodeficiency Virus–Coinfected
Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure
Hepatitis C Virus Diagnosis and the Holy Grail
A Guide to the Economics of Hepatitis C Virus Cure in 2017
Estimation of Hepatitis C Disease Burden and Budget Impact of Treatment
Using Health Economic Modeling
The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System’s Perspective
- Edition: 1
- Latest edition
- Volume: 32-2
- Published: May 24, 2018
- Language: English
CG
Camilla S. Graham
Affiliations and expertise
Harvard Medical School, Boston, MAST
Stacey B. Trooskin
Affiliations and expertise
Drexel University College of Medicine, Philadelphia, PA